NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-344-2013-0-PCT-02 Development of Human Monoclonal Antibodies Against Tumor Endothelial Marker 8 (TEM8) as Cancer Diagnostic and Therapeutic PCT PCT PCT/US2014/060299 Expired
NIDDK E-743-2013-0-PCT-02 TREATMENT OF CHRONIC KIDNEY DISEASE WITH SAHPS PCT PCT PCT/US2014/060304 Expired
NHLBI E-759-2013-0-PCT-02 Vascular Dilators PCT PCT PCT/US2014/060270 Expired
NIAID E-531-2013-2-BR-02 Epstein-Barr Virus Vaccines BR National Stage BR112016007868-3 Issued
NCATS E-757-2013-2-EP-03 4-((2-HYDROXY-3-METHOXYBENZYL)AMINO) BENZENESULFONAMIDE DERIVATIVES AS 12-LIPOXYGENASE INHIBITORS EP National Stage 14852765.8 Issued
NCATS E-757-2013-2-CA-02 4-((2-HYDROXY-3-METHOXYBENZYL)AMINO) BENZENESULFONAMIDE DERIVATIVES AS 12-LIPOXYGENASE INHIBITORS CA National Stage 2926950 Issued
NIAID E-531-2013-2-IN-05 EPSTEIN BARR VIRUS VACCINES IN National Stage 201617016021 Issued
NIAID E-531-2013-2-IE-14 Epstein-Barr Virus Vaccines IE EP 14799574.0 Issued
NIAID E-531-2013-2-DE-11 Epstein-Barr Virus Vaccines DE EP 14799574.0 Issued
NIAID E-531-2013-2-CZ-10 Epstein-Barr Virus Vaccines CZ EP 14799574.0 Issued
NIAID E-531-2013-2-BE-09 Epstein-Barr Virus Vaccines BE EP 14799574.0 Issued
NIAID E-531-2013-2-FR-12 Epstein-Barr Virus Vaccines FR EP 14799574.0 Issued
NIAID E-531-2013-2-SE-15 Epstein-Barr Virus Vaccines SE EP 14799574.0 Issued
NIAID E-531-2013-2-EP-04 Epstein-Barr Virus Vaccines EP National Stage 14799574.0 Issued
NIAID E-531-2013-2-GB-13 Epstein-Barr Virus Vaccines GB EP 14799574.0 Issued
NIAID E-531-2013-2-CN-03 Epstein-Barr Virus Vaccines CN National Stage 201480066333.2 Issued
NCI E-040-2012-0-ID-11 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen ID National Stage P-00201406162 Issued
NCI E-040-2012-0-JP-15 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen JP National Stage 2015-505765 Issued
NCATS E-757-2013-2-PCT-01 4-((2-HYDROXY-3-METHOXYBENZYL)AMINO) BENZENESULFONAMIDE DERIVATIVES AS 12-LIPOXYGENASE INHIBITORS PCT PCT PCT/US14/60174 Expired
NIAID E-531-2013-2-PCT-01 Novel Epstein-Barr Virus Vaccines PCT PCT PCT/US2014/060142 Expired
NCI E-040-2012-0-TH-21 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen TH National Stage 1401006159 Pending
NIAID E-188-2015-0-GB-01 POLYMER ADJUVANT GB ORD 1418004.6 Abandoned
NCI E-263-2014-0-US-01 Methods To Eliminate Cancer Stem Cells By Targeting CD47 US 62/062,675 Abandoned
NIDCR E-736-2013-1-EP-03 Detection of Hepatitis Delta Virus (HDV) For the Diagnosis and Treatment of Sjorgren's Syndrome and Lymphoma EP National Stage 14790440.3 Issued
NIDCR E-736-2013-1-GB-06 Detection of Hepatitis Delta Virus (HDV) For the Diagnosis and Treatment of Sjorgren's Syndrome and Lymphoma GB EP 14790440.3 Issued
NIDCR E-736-2013-1-FR-05 Detection of Hepatitis Delta Virus (HDV) For the Diagnosis and Treatment of Sjorgren's Syndrome and Lymphoma FR EP 14790440.3 Issued
NIDCR E-736-2013-1-DE-04 Detection of Hepatitis Delta Virus (HDV) For the Diagnosis and Treatment of Sjorgren's Syndrome and Lymphoma DE EP 14790440.3 Issued
NCI E-040-2012-0-MX-17 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen MX National Stage MX/a/2014/012222 Issued
NCATS E-326-2008-0-JP-09 Activators Of Human Pyruvate Kinase JP DIV 2014-207672 Issued
NIDCR E-736-2013-1-PCT-01 Detection of Hepatitis Delta Virus For The Diagnosis and Treatment of Sojgrens Syndrome And Lymphoma PCT PCT COMB PCT/US2014/059825 Expired
NIBIB E-001-2015-0-US-01 Microfluidic Device and System for Analyzing Shear Forces in Blast-Induced Traumatic Brain Injuries US 62/062,053 Abandoned
NCI E-040-2012-0-SG-20 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen SG National Stage 11201406414W Issued
NCI E-001-2014-0-PCT-02 ANTIBODIES THAT SPECIFICALLY BIND ATAXIA TELANGIECTASIA-MUTATED AND RAD3-RELATED KINASE PHOSPHORYLATED AT POSITION 1989 AND THEIR USE PCT PCT PCT/US2014/059759 Expired
NCI E-040-2012-0-BR-05 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen BR National Stage BR112014024893-1 Issued
NCI E-269-2003-0-US-04 Composition for Detecting the Response of Rectal Adenocarcinomas to Radiochemotherapy US CON 14/507,707 Abandoned
NCI E-040-2012-0-IS-14 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen IS National Stage EU9056 Pending
NCI E-771-2013-4-TW-06 Modified Pseudomonas Exotoxin A TW ORD 103134804 Abandoned
NIAID E-124-2009-0-RU-17 Influenza Hemagglutinin And Neuraminidase Variants RU DIV 2014140731 Abandoned
NCI E-771-2013-4-EP-11 Modified Pseudomonas Exotoxin A EP National Stage 14789449.7 Abandoned
NCI E-771-2013-4-AU-08 Modified Pseudomonas Exotoxin A AU National Stage 2014329437 Abandoned
NCI E-771-2013-4-US-02 Modified Pseudomonas Exotoxin A US ORD 14/505,590 9388222 Abandoned PDF
NCI E-771-2013-4-PCT-01 Modified Pseudomonas Exotoxin A PCT PCT COMB PCT/US2014/058941 Expired
NCI E-771-2013-4-AR-03 Modified Pseudomonas Exotoxin A AR ORD 20140103701 Abandoned
NCI E-771-2013-4-IN-12 Modified Pseudomonas Exotoxin A IN National Stage 201647015226 Abandoned
NCI E-771-2013-4-CA-09 Modified Pseudomonas Exotoxin A CA National Stage 2926215 Abandoned
NIMH E-252-2014-0-US-01 Magnetic Resonance Magnification Imaging US 62/059,520 Abandoned
NCI E-233-2014-0-GB-22 Methods of Isolating T Cell Receptors Having Antigenic Specificity for a Cancer-Specific Mutation GB EP 14796317.7 Issued
NCI E-233-2014-0-EP-05 Methods of Isolating T Cell Receptors Having Antigenic Specificity for a Cancer-Specific Mutation EP National Stage 14796317.7 Issued
NCI E-233-2014-0-DE-15 Methods of Isolating T Cell Receptors Having Antigenic Specificity for a Cancer-Specific Mutation DE EP 14796317.7 Issued
NCI E-233-2014-0-NL-17 Methods of Isolating T Cell Receptors Having Antigenic Specificity for a Cancer-Specific Mutation NL EP 14796317.7 Issued